期刊文献+

TGF-β_2刺激人Tenon囊成纤维细胞增殖,表达CTGF和合成Fn 被引量:5

TGF-β_2 induces human Tenon's capsule fibroblasts to proliferate, express CTGF and fibronectin
下载PDF
导出
摘要 目的:研究转化生长因子(TGF-β2)和结缔组织生长因子(CTGF)在滤过泡瘢痕化中的作用。方法:用不同浓度的TGF-β2刺激HTF,然后用RT-PCR和免疫细胞化学法分别检测CTGF和Fn的表达,用MTT法检测细胞的增殖。结果:TGF-β22μg/L到5μg/L范围有剂量依赖性地促进HTF的细胞增殖,CTGF的表达和Fn的合成的趋势(P<0.01),但0.5μg/L,1μg/L与正常对照组对细胞的增殖作用差别无显著性,5μg/L与10μg/L增强细胞的增殖作用也无显著性差异(P>0.05)。结论:TGF-β2能够明显地促进HTF细胞增殖,并增强其下游介质(CTGF)的表达和合成细胞外基质-纤维连接蛋白(fibronetin,Fn)。 AIM: To investigate the influence of transforming growth factor-13 2 and connective tissue growth factor on the human Tenon's capsule fibroblasts. METHODS: The proliferation of HTF treated by different concentration of TGF-β 2 was detected by using MTT colorimetry, and the expression of CTGF and fibronectin was detected by RT-PCR and immunocytochemistry assay respectively. Imaging and statistical analysis was used to evaluate the effect of transforming growth factor. RESULTS: MTT method: the induction of TGF-β 2 (2, 4 and 5μg/L) showed a promotion on the proliferation of HTF and the expression of CTGF and fibronectin (P〈0.01),while 0.5μg/L and 1μg/L group vs. normal group, 5μg/L group vs 10μg/L group had no significant difference on the proliferation of HTF (P〉0.05). CONCLUSION: TGF- β2 can enhance the proliferation of the HTF and induce the expression of CTGF and Fn in a dose-dependent manner, inferring that CTGF may be an important cytokine in scarring after glaucoma filtering surgery as a downstream mediator of TGF-β 2 action.
出处 《国际眼科杂志》 CAS 2006年第4期796-798,共3页 International Eye Science
关键词 结缔组织生长因子 转化生长因子-Β2 纤维连接蛋白 TENON囊成纤维细胞 青光眼滤过术 connective tissue growth factor transforming growth factor-β 2 fibronectin Tenon's capsule flbroblasts glaucoma filtering surgery
  • 相关文献

参考文献13

二级参考文献16

  • 1陈松.青光眼滤过性手术中抗瘢痕形成药物的研究近况[J].国外医学(眼科学分册),1994,18(4):193-201. 被引量:55
  • 2张欣,梁春玲,徐彦,郭素平.非穿透性小梁手术中应用丝裂霉素C32例[J].国际眼科杂志,2005,5(1):107-111. 被引量:16
  • 3Shaarawy T, Karlen M, Schnyder C, Achache F, Sanchez E, Mermoud A.Five-year results of deep sclerectomy with collagen implant [J]. J Cataract Refract Surg ,2001 ;27:1770-1778.
  • 4Marchini G, Marraffa M, Brunelli C, Morbio R, Bonomi L. Ultrasound biomicroscopy and intraocular-pressure-lowering mechanisms of deep sclerectomy with reticulated hyaluronic acid implant [J].J Cataract Refract Surg,2001;27:507-517.
  • 5Sourdille P, Santiago PY, Villain F, Yamamichi M, Tahi H, Parel JM,Ducournau Y. Reticulated hyaluronic acid implant in nonpefforating trabecular surgery [J].J Cataract Refract Surg,1999;25:332-339.
  • 6Karlen ME, Sanchez E, Schnyder CC, Sickenberg M, Mermoud A. Deepsclerectomy with collagen implant: medium term results [J]. Br.J Ophthalmol,1999;83:6-11.
  • 7Dahan E, Ophth M, Drusedau MU. Nonpenetrating filtration surgery for glaucoma: control by surgery only [J]. J Cataract Refract Surg,2000;26:695-701.
  • 8Moussad EE,Brgstock DR.Connective tissue growth factor:what's in a name ? [J] Mol Genet Metab,2000,71:276-292
  • 9Grotendorst GR.Connective tissue growth factor:a mediator of TGF-beta action on fibroblasts [J].Cytok Growth Fact Rev,1997,8:171-179
  • 10Cordeiro MF,Bbattacbarya SS,Schultz GS,et al.TGF-β1,-β2,-β3 in vitro:biphasic effects on Tenon's capsule fibroblast contraction,proliferation,and migration[J].Invest Ophthalmol Vis Sci,2000,41:756-763

共引文献36

同被引文献49

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部